These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25046793)

  • 1. Tranexamic acid: more than inhibition of fibrinolysis?
    Couturier R; Grassin-Delyle S
    Anesth Analg; 2014 Aug; 119(2):498-499. PubMed ID: 25046793
    [No Abstract]   [Full Text] [Related]  

  • 2. New insights about the use of tranexamic acid in children undergoing cardiac surgery: from pharmacokinetics to pharmacodynamics.
    Faraoni D; Goobie SM
    Anesth Analg; 2013 Oct; 117(4):760-762. PubMed ID: 24057950
    [No Abstract]   [Full Text] [Related]  

  • 3. In response.
    Yee BE; Eaton MP
    Anesth Analg; 2014 Aug; 119(2):499. PubMed ID: 25046794
    [No Abstract]   [Full Text] [Related]  

  • 4. The effective concentration of tranexamic acid for inhibition of fibrinolysis in neonatal plasma in vitro.
    Yee BE; Wissler RN; Zanghi CN; Feng C; Eaton MP
    Anesth Analg; 2013 Oct; 117(4):767-772. PubMed ID: 24023015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies.
    Picetti R; Shakur-Still H; Medcalf RL; Standing JF; Roberts I
    Blood Coagul Fibrinolysis; 2019 Jan; 30(1):1-10. PubMed ID: 30585835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of tranexamic acid and ε-aminocaproic acid concentrations required to inhibit fibrinolysis in plasma of dogs and humans.
    Fletcher DJ; Blackstock KJ; Epstein K; Brainard BM
    Am J Vet Res; 2014 Aug; 75(8):731-8. PubMed ID: 25061704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous or discontinuous tranexamic acid effectively inhibits fibrinolysis in children undergoing cardiac surgery with cardiopulmonary bypass.
    Couturier R; Rubatti M; Credico C; Louvain-Quintard V; Anerkian V; Doubine S; Vasse M; Grassin-Delyle S
    Blood Coagul Fibrinolysis; 2014 Apr; 25(3):259-65. PubMed ID: 24418941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postinjury fibrinolysis shutdown: Rationale for selective tranexamic acid.
    Moore EE; Moore HB; Gonzalez E; Chapman MP; Hansen KC; Sauaia A; Silliman CC; Banerjee A
    J Trauma Acute Care Surg; 2015 Jun; 78(6 Suppl 1):S65-9. PubMed ID: 26002266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma tranexamic acid concentrations during cardiopulmonary bypass.
    Fiechtner BK; Nuttall GA; Johnson ME; Dong Y; Sujirattanawimol N; Oliver WC; Sarpal RS; Oyen LJ; Ereth MH
    Anesth Analg; 2001 May; 92(5):1131-6. PubMed ID: 11323334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.
    Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O
    Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CRASH-2 trial of an antifibrinolytic agent in traumatic haemorrhage: an international collaboration.
    Roberts I
    Indian J Med Res; 2007 Jan; 125(1):5-7. PubMed ID: 17332649
    [No Abstract]   [Full Text] [Related]  

  • 12. Is tranexamic acid exposure related to blood loss in hip arthroplasty? A pharmacokinetic-pharmacodynamic study.
    Lanoiselée J; Zufferey PJ; Ollier E; Hodin S; Delavenne X;
    Br J Clin Pharmacol; 2018 Feb; 84(2):310-319. PubMed ID: 29193211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desmoteplase-mediated plasminogen activation and clot lysis are inhibited by the lysine analogue tranexamic acid.
    Niego B; Horvath A; Coughlin PB; Pugsley MK; Medcalf RL
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):322-4. PubMed ID: 18469556
    [No Abstract]   [Full Text] [Related]  

  • 14. The Use of Thromboelastography to Titrate Tranexamic Acid Therapy for Abatement of Lysis-Induced Hemorrhagic Complications During Venoarterial Extracorporeal Membrane Oxygenation.
    Seelhammer TG; Mangla J; Demirci O
    J Cardiothorac Vasc Anesth; 2019 Apr; 33(4):1059-1062. PubMed ID: 30765211
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of effectiveness of tranexamic acid and epsilon-amino-caproic-acid in decreasing postoperative bleeding in off-pump CABG surgeries: A prospective, randomized, double-blind study.
    Verma S; Srinivas U; Sathpathy AK; Mittal P
    Ann Card Anaesth; 2020; 23(1):65-69. PubMed ID: 31929250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance and practical assessment of fibrinolysis shutdown.
    Moore HB; Moore BA; Sauaia A; Moore EE
    ANZ J Surg; 2020 Apr; 90(4):413-414. PubMed ID: 31535453
    [No Abstract]   [Full Text] [Related]  

  • 17. Tranexamic acid disturbs the dynamics of postinjury fibrinolysis.
    Coleman JR; Moore EE; Moore HB; Chapman MP; Cohen MJ; Silliman CC; Sauaia A
    ANZ J Surg; 2020 Apr; 90(4):420-422. PubMed ID: 32339428
    [No Abstract]   [Full Text] [Related]  

  • 18. Anaphylaxis with associated fibrinolysis, reversed with tranexamic acid and demonstrated by thrombelastography.
    De Souza RL; Short T; Warman GR; Maclennan N; Young Y
    Anaesth Intensive Care; 2004 Aug; 32(4):580-7. PubMed ID: 15675222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic plasma concentrations of epsilon aminocaproic acid and tranexamic acid in horses.
    Fletcher DJ; Brainard BM; Epstein K; Radcliffe R; Divers T
    J Vet Intern Med; 2013; 27(6):1589-95. PubMed ID: 24118238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and cerebral spinal fluid tranexamic acid quantitation in cardiopulmonary bypass patients.
    Abou-Diwan C; Sniecinski RM; Szlam F; Ritchie JC; Rhea JM; Tanaka KA; Molinaro RJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Mar; 879(7-8):553-6. PubMed ID: 21300577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.